Unlock instant, AI-driven research and patent intelligence for your innovation.
A treatment agent for reducing background luminescence value of immunodiagnostic reagents and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of immunodiagnosis and treatment agent, which is applied in the field of treatment agent and its preparation for reducing the background luminescence value of immunodiagnostic reagents, and can solve the problems of high background luminescence value and reduction of background luminescence value of immunodiagnostic reagents, etc.
Active Publication Date: 2021-04-30
GUANGZHOU KEFEN BIOTECH CO LTD
View PDF8 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] In order to overcome the deficiencies in the prior art, one of the purposes of the present invention is to provide a treatment agent that reduces the background luminescence value of immunodiagnostic reagents, which can effectively solve the problem of excessive background luminescence value in immunodiagnostic reagents, greatly improving The sensitivity and product quality of the product can meet the clinical requirements to reduce the occurrence of misdiagnosis
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0030] A method for preparing a treatment agent for reducing the background luminescence value of an immunodiagnostic reagent, comprising the following preparation steps:
[0031] Add 0.05% tetramethylammonium chloride, 0.05% 2-bromoethyltrimethylammonium bromide, 0.1% Tween-20, 0.1% EDTA, 0.1% alkylbenzenesulfonate, 0.1 % alkyl sulfonate, 0.1% alkyl glyceryl ether sulfonate, after mixing, adjust the pH value to 6.3, that is.
Embodiment 2
[0033] A method for preparing a treatment agent for reducing the background luminescence value of an immunodiagnostic reagent, comprising the following preparation steps:
[0034] Add 0.1% tetramethylammonium chloride, 0.1% 2-bromoethyltrimethylammonium bromide, 0.1% Tween-20, 0.1% EDTA, 0.25% alkylbenzenesulfonate, 0.25 % alkyl sulfonate, 0.25% alkyl glyceryl ether sulfonate, after mixing, adjust the pH value to 6.3, that is.
Embodiment 3
[0036] A method for preparing a treatment agent for reducing the background luminescence value of an immunodiagnostic reagent, comprising the following preparation steps:
[0037] Add 0.2% tetramethylammonium chloride, 0.2% 2-bromoethyltrimethylammonium bromide, 0.1% Tween-20, 0.1% EDTA, 0.5% alkylbenzenesulfonate, 0.5 % alkyl sulfonate, 0.5% alkyl glyceryl ether sulfonate, after mixing, adjust the pH value to 6.3, that is.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a treatment agent for reducing the background luminescence value of immunodiagnostic reagents, which comprises the following components by mass: 0.05-0.4 parts of a catalyst; 0.1-1.5 parts of a surfactant; 0.1-0.2 parts of a chelating agent; 0.1-1.5 parts of acid salt compounds. The treatment agent of the present invention is applied to immunodiagnostic reagents, which can effectively solve the problem that the background luminescence value is too high and affect the accuracy of clinical low-concentration specimen measurement, greatly improve the sensitivity and product quality of the product, and can meet clinical requirements. Occurrence of misdiagnosis. The invention also provides a preparation method of a treatment agent for reducing the background luminescence value of the immunodiagnostic reagent.
Description
technical field [0001] The invention relates to the technical field of immunodiagnostic reagents, in particular to a treatment agent for reducing the background luminescence value of immunodiagnostic reagents and a preparation method thereof. Background technique [0002] Immunodiagnosis belongs to one subdivision of the field of in vitro diagnostic reagents. Immunodiagnosis is the application of immunological theories, techniques and methods to diagnose various diseases. Immunodiagnostic reagents have the most varieties in diagnostic kits, and are widely used in hospitals, blood stations, and physical examination centers, mainly for hepatitis testing, STD testing, tumor testing, pregnancy testing, etc. [0003] Immunodiagnosis includes radioimmunoassay, enzyme-linked immunoassay, chemiluminescence, etc. The immunodiagnostic detection method is a series of experimental methods for the determination of antigens and antibodies designed by applying the theory of immunology. T...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.